Send me real-time posts from this site at my email
Zacks

Company News for Aug 30, 2021

  • Shares of Ubiquiti Inc. UI jumped 7.1% after the company reported fourth-quarter fiscal 2021 earnings of $2.46 per share, beating the Zacks Consensus Estimate of $2.35.
  • Chembio Diagnostics, Inc.’s CEMI shares surged 11.2% after the company announced its launch of commercial distribution of SCOV-2 Ag Detect Rapid Test, a third party COVID-19 antigen test.
  • Shares of Gambling.com Group Limited GAMB jumped 66.9% after the company announced receiving temporary supplier license by Arizona Department of Gaming to provide marketing services for licensed operators in the state.
  • Kanzhun Limited’s BZ shares rose 3.7% after the company reported second-quarter 2021 earnings of 20 cents per share, outpacing the Zacks Consensus Estimate of 7 cents.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chembio Diagnostics, Inc. (CEMI): Free Stock Analysis Report
 
KANZHUN LIMITED Sponsored ADR (BZ): Free Stock Analysis Report
 
Ubiquiti Inc. (UI): Free Stock Analysis Report
 
Gambling.com Group Limited (GAMB): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue